[The current state of substitution treatment in congenital emphysema due to alpha-1-antitrypsin deficiency. The report of the National Registry] (Q73268721)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1999

Language	Label	Description	Also known as
English	[The current state of substitution treatment in congenital emphysema due to alpha-1-antitrypsin deficiency. The report of the National Registry]	scientific article published on 01 October 1999

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

[The current state of substitution treatment in congenital emphysema due to alpha-1-antitrypsin deficiency. The report of the National Registry] (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

pulmonary emphysema

1 reference

based on heuristic

inferred from title

author name string

M Miravitlles

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Vidal

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J C Barros-Tizón

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Bustamante

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P P España

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Casas

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M T Martínez

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Escudero

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Jardí

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Archivos de Bronconeumologia

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

35

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

446-454

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The molecular structure and pathology of alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

PI(alpha 1-antitrypsin) polymorphism in the Japanese: confirmation of PI*M4 and description of new PI variants

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha 1-antitrypsin phenotypes in Northern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of alpha-1-antitrypsin (Pi) phenotypes in Denmark determined by separator isoelectric focusing in agarose gel.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Smoking, lung function, and alpha 1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific Antibody Response Against the 23-Valent Pneumococcal Vaccine in Patients With α1-Antitrypsin Deficiency With and Without Bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of Mortality in Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Body mass index and mortality in patients with severe alpha 1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary disease in alpha-1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary evidence that augmentation therapy diminishes degradation of cross-linked elastin in alpha-1-antitrypsin-deficient humans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Design of a Clinical Trial to Test a Treatment of the Underlying Cause of Emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

[The evolution of the replacement treatment of emphysema due to alpha 1-antitrypsin deficiency]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trials needed for alpha 1-antitrypsin replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-1-antitrypsin replacement therapy: will its efficacy ever be proved?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

[Evaluation of replacement therapy in emphysema caused by alpha 1-antitrypsin deficiency]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

[Should we administer replacement therapy to patients with alpha-1-antitrypsin deficit?]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inactivation of alpha 1-proteinase inhibitor by alveolar inflammatory cells from smoking patients with or without emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased C4 complement component serum levels correlate with the degree of emphysema in patients with chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial measurements of FEV1 over 12 years in a patient with alpha-1-protease inhibitor deficiency:influence of augmentation therapy and infections

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year results after lung volume reduction surgery in alpha1-antitrypsin deficiency versus smoker's emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimated growth of lung volume reduction surgery among Medicare enrollees: 1994 to 1996

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute allergic reaction and demonstration of specific IgE antibodies against alpha-1-protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

[A report on the Spanish Registry of Patients with Alpha 1-Antitrypsin Deficiency. The Alpha 1-Antitrypsin Deficiency Study Group]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum Pi types in some European, American, Asian and African populations

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

[Usefulness of the quantification of the alpha-1 serous protein band in the screening of alpha-1-antitrypsin deficiency]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of alpha 1-antitrypsin in homozygous PiZ deficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic study of alpha1-antitrypsin infusion in alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha 1-proteinase inhibitor (human) shortage

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-2896%2815%2930041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0300-2896(15)30041-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10596342%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73268721&oldid=1933731963"